Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/10/25 08:06 | 4/8/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Lukatch Heath | CA | D | 1 | M.d | 117 | 16.78 | 0 | 7 | 98 | 14 | D | |||||||||||||||
4/9/25 08:05 | 4/7/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 5 | M.d | 1,549 | 42.11 | 0 | 37 | 39 | 132 | D | ||||||||||||||
4/7/25 07:38 | 4/4/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 1 | M.d | 184 | 8.96 | 0 | 21 | 3 | 791 | D | ||||||||||||||
3/7/25 16:43 | 3/5/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Eydelman Mikhail | CA | O | SVP,GC,C | 4 | M.d | 1,018 | 50.91 | 0 | 20 | 93 | 42 | D | ||||||||||||||
3/7/25 16:43 | 3/5/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Eydelman Mikhail | CA | O | SVP,GC,C | 4 | S.d | -1,018 | 50.91 | 0 | -20 | 42 | D | |||||||||||||||
3/3/25 21:14 | 3/3/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | COO | 4 | M.d | 1,330 | 41.57 | 0 | 32 | 18 | 206 | D | ||||||||||||||
3/3/25 21:14 | 3/3/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | COO | 4 | S.d | -1,330 | 41.57 | 0 | -32 | 206 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |